Iron Supplementation in TAVI and SAVR Patients With Iron Deficiency
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 2500 participants.
Also called NCT04786769
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 2,500 participants
- Sponsor
- Hospital de Santa Cruz, Portugal
- Registry
-
NCT04786769
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT04786769. Randomized; quadruple masking; primary purpose treatment. Start 2022-01 (anticipated); primary completion 2025-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Iron Supplementation in TAVI and SAVR Patients With Iron Deficiency
- Acronym
- INERTIA
- Condition
- Aortic Stenosis
- Condition
- Iron-deficiency
- Intervention (Drug)
- Ferric carboxymaltose
- Lead sponsor
- Hospital de Santa Cruz, Portugal
Record details
- Record id
cardio:ct-nct04786769- Content hash
d18ca0f35b5be490706abc437846be6cde7614579109d27310d8d4a7722e7c8d